Building an Organizational Ethics Program on a Clinical Ethics Foundation.


Journal

The Journal of clinical ethics
ISSN: 1046-7890
Titre abrégé: J Clin Ethics
Pays: United States
ID NLM: 9114645

Informations de publication

Date de publication:
2020
Historique:
entrez: 22 9 2020
pubmed: 23 9 2020
medline: 1 12 2020
Statut: ppublish

Résumé

Organizational ethics programs often are created to address tensions in organizational values that have been identified through repeated clinical ethics consultation requests. Clinical ethicists possess some core competencies that are suitable for the leadership of high-quality organizational ethics programs, but they may need to develop new skills to build these programs, such as familiarity with healthcare delivery science, healthcare financing, and quality improvement methodology. To this end, we suggest that clinical ethicists build organizational ethics programs incrementally and via quality improvement projects undertaken in collaboration with senior clinical leaders. Organizational ethics programs often differ from clinical ethics programs in their membership and processes, and likely will require ethicists to forge new partnerships with a wide array of organizational leaders. With attention to the ways that organizational ethics programs differ from clinical ethics programs, and investment in quality improvement methodology and formal institutional needs assessments, clinical ethics leaders can position an organizational ethics program to advocate effectively for visible and compelling alignment of leadership decision making with the values of the organization.

Identifiants

pubmed: 32960808
pii: 2020313259
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-267

Informations de copyright

Copyright 2020 The Journal of Clinical Ethics. All rights reserved.

Auteurs

Timothy Lahey (T)

University of Vermont Medical Center, UVM's Larner College of Medicine, Burlington, Vermont USA. Timothy.Lahey@UVMhealth.org.

Evan G DeRenzo (EG)

John J. Lynch, MD, Center for Ethics, Medstar Washington Hospital Center, Washington, District of Columbia USA. Evan.G.Derenzo@Medstar.net.

Joshua Crites (J)

Staff Ethicist, Center for Bioethics, Cleveland Clinic, Cleveland, Ohio USA. critesj@ccf.org.

Joseph Fanning (J)

Clinical Ethics Consultation Service and Vanderbilt University Medical Center, Nashville, Tennessee USA. joe.fanning@vanderbilt.edu.

Barrie J Huberman (BJ)

Division of Medical Ethics, Weill Cornell Medical College; and Medical Ethics, New York Presbyterian Weill Cornell Medicine, New York, New York USA. bjh4001@med.cornell.edu.

John Paul Slosar (JP)

Healthcare Ethics, Ascension Health, St. Louis, Missouri USA. jslosar@ascension.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH